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Vibrational Spectroscopy, both infrared absorption and Raman spectroscopy, have attracted increasing attention for
biomedical applications, from in vivo and ex vivo disease diagnostics and screening, to in vitro screening of therapeutics.
There remain, however, many challenges related to the accuracy of analysis of physically and chemically inhomogeneous
samples, across heterogeneous sample sets. Data preprocessing is required to deal with variations in instrumental
responses and intrinsic spectral backgrounds and distortions in order to extract reliable spectral data. Data postprocessing
is required to extract the most reliable information from the sample sets, based on often very subtle changes in spectra
associated with the targeted pathology or biochemical process. This review presents the current understanding of the
factors influencing the quality of spectra recorded and the pre-processing steps commonly employed to improve on
spectral quality. It further explores some of the most common techniques which have emerged for classification and
analysis of the spectral data for biomedical applications. The importance of sample presentation and measurement
conditions to yield the highest quality spectra in the first place is emphasised, as is the potential of model simulated
datasets to validate both pre- and post- processing protocols.

Introduction
The potential of vibrational spectroscopy, both Infrared (IR)
absorption and Raman scattering, for biomedical applications has
been well established through many proof of concept studies over
the past decades. Due to its unique chemical fingerprinting
capability at the molecular level, vibrational spectroscopy can play a
significant role in a new paradigm of histopathology, cytology,
biopsy targeting, surgical targets, treatment monitoring and drug
studies. However, translation into the clinical environment has
been slow, and although the challenges facing the translation to
realistic clinical applications are manifold, including those
associated with large scale clinical trials, health economics and
acceptance by the medical community [1], there remains a
considerable amount of issues relating to the fundamental process
of recording reliable spectra from complex, chemically and
physically inhomogeneous samples and extracting reliable
information from heterogeneous sample sets which may be
influenced by a multitude of confounding factors.
The development of reliable data (pre- and post-) processing and
data mining techniques has thus been identified as a rate
determining step in the maturation of vibrational spectroscopic
techniques towards real applications, in vitro, ex vivo and in vivo.
Instrumental response functions and sample presentation can
significantly impact on the quality of the data gathered. Both tissues
and cells are physically and chemically inhomogeneous and can give
rise to a number of artifacts which can distort and greatly reduce

the accuracy of a spectral measurement. IR absorption and Raman
spectroscopy are very distinct physical processes [2], and therefore
the spectral distortions can be of very different physical origin.
Although many biomedical applications of the techniques have
been targeted towards disease diagnostics, for which high
specificity and sensitivity classification algorithms are desirable,
more recent applications have been targeted at, for example,
disease aetiology [3,4], radiation dosimetry [5], drug screening [610] and nanotoxicology [11-13], for which a range of other data
mining and analysis protocols have been explored [14]. It is
important, however, that these protocols are well validated, in
order to progress the field with confidence.
This Special Issue Review attempts to summarise the current
understanding of the underlying physical factors influencing the
quality of spectra recorded, for both IR absorption and Raman
spectroscopy, and the pre-processing steps commonly employed to
improve on spectral quality, while emphasising the importance of
sample presentation and measurement conditions to yield the
highest quality spectra in the first instance. The review focusses on
established Raman and IR techniques, rather than emerging
techniques based on enhanced or stimulated effects [15]. It
explores some of the most common techniques which have
emerged for classification and analysis of the spectral data for
biomedical applications. The potential of model simulated datasets
to validate both pre- and post- processing protocols is highlighted.

Spectral Preprocessing:
spectroscopy

InfraRed

absorption

In IR spectroscopy, commonly performed in transmission or
transmission/reflection (transflection) mode, the absorption
features are typically found to sit on top of a large, broad and
undulating background. On the basis that the background is slowly
varying with respect to the absorption features of interest, first and
even second order differentiation of the spectra has been
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employed to remove the background, accentuating the desired
spectral features. Such an approach assumes that the features
themselves are not impacted by the underlying physical effects,
however, an assumption which cannot be assumed to be valid
based on a better understanding of their origin.
Mie scattering of the incident radiation, of wavelength ~2-10m, by
cellular components of similar length-scale, has been identified as
the source of the broad undulating background commonly observed
[16]. The undulating background of FTIR absorption spectra can be
satisfactorily removed using the so called Extended Multiplicative
Scatter Correction (EMSC) protocol [17], derived from the
multiplicative signal correction (MSC), which is an algorithm for
removal of additive and multiplicative contributions from a given
interfering signal. Offsets and baseline slopes are removed
effectively, whilst the multiplicative part of the algorithm
compensates for differences in optical path length, effectively
normalising the spectra. This is done by taking a reference
spectrum, which can be the mean spectrum of the sample data set
or a spectrum with similar spectral features. The algorithm takes
the reference spectrum and attempts to recreate the raw spectrum
to be corrected by adding an offset, a slope and amplifying the
reference by multiplication. However, it is apparent that the
absorption features themselves are also distorted, an effect which
is most obviously manifest by a dip in the absorption profile on the
-1
high wavenumber side of the amide I feature at ~1675cm , the socalled “Dispersion Artifact” [16] (see for example Figure 1), and can
cause a shift in the apparent maximum of all spectral features. Until
recently, the physical origin of this has been unclear [16]. While Mie
scattering is commonly considered to derive from the imaginary
component of the refractive index of the scattering material, using
simulated data and chemically homogeneous model systems, the
artifact has been recently demonstrated to have origin in
contributions of the real component of the refractive index in the
form of resonant reflection (in transflection mode) [18] and
resonant Mie scattering (in transmission mode), although it should
be noted that both resonant reflection and scattering artefacts can
contribute in both measurement geometries [19]. The real and
imaginary components of the refractive index are related via the
Kramer-Kronig relationship and thus the absorption and (resonant)
scattering profiles are intimately related [18]. Understanding the
physical origin of the effects has led to a refinement of the EMSC
protocol (RMieS-EMSC), by incorporation of resonant contributions
to the sample refractive index, to efficiently account for and correct
spectra for the effects [20, 21] (figure 1). A full description of the
EMSC and RMieS-EMSC protocols is provided in [21]. An alternative,
more supervised approach to spectral correction using undistorted
spectra as standards has been proposed by Bird et al. [22].
Notably, in the development of the correction algorithm, a better
fundamental understanding of the physical origin of the effects was
critical, and the use of model systems and simulated data sets was
invaluable in validating the protocol. Independent of correction
algorithm employed, the increased understanding of the physical
origins of the spectral distortions implies that IR spectra as a
representation of chemical variations within biological materials
can now be interpreted with a significantly higher degree of
confidence.
Despite the greater understanding of the physical origin of the socalled dispersion artefacts, there remains much debate on the
questions of measurement geometry for IR absorption
spectroscopy, and therefore optimum choice of substrates. In terms
of cost, low-E, reflective slides appear most attractive, implying the
use of a transflection measurement configuration. However,

questions have been raised concerning additional spectral artefacts
which can result from the so called “Electric Field Standing Wave”
effect in such measurements [23]. On reflection from any metallic
surface, the electric field of the radiation is pinned with a node at
the reflecting surface, and a standing wave above it. For varying
frequencies, the electric field distribution is different, having nodes
and anti-nodes at different heights above the surface. A sample of
defined thickness on such a surface will experience different
intensity distributions across the spectrum, and therefore the
absorbance spectrum can be distorted. It has been argued,
however, that the effects are diminished by thickness
inhomogeneities, the range of sampling angles, and the source
incoherence [24]. The alternative, transmission, geometry requires
(at least partially) transparent substrates. It has been demonstrated
that even glass substrates may provide transmission in a sufficiently
broad (high wavenumber) region to provide diagnostic capabilities
[25]. However, access to the broader spectrum is only provided by
more costly polycrystalline substrates such as CaF2. In terms of
translation to a clinical environment, choice of substrate may
ultimately be dictated by cost, and therefore by sample throughput
and by the target application. A full cost analysis is required to
assess the relative demand and costs of applications for (i) near
patient intra operative diagnostic (ii) postoperative histological and
(iii) research purposes. Establishing the relative impact of the
spectral distortions associated with the EFSW effect compared to
the target intrinsic biochemical variations may be critical in reaching
a decision over clinical applications of IR absorption for spectral
histopathology.

Figure 1: Correction of FTIR spectra for non and resonant Mie
scattering (Reproduced from royal Society of Chemistry [20]).
In terms of sample presentation, fresh frozen sections are
recommended as the tissue architecture and biochemistry is kept
largely intact and, notably, the lipidic information can be accessed
[26]. Furthermore, they are more amenable to combining
immunohistochemistry,
proteomics,
and
biospectroscopy.
However, clinically, fresh tissue is normally only used for
intraoperative work and stained, fixed sections are preferred for
histopathology [27]. Therefore, standardised protocols for
spectroscopic analysis of Formalin Fixed Paraffin Processed (FFPP)
tissue samples are of paramount importance. Notably, analyses of
archived tissue libraries may add much to understanding disease
progression and patient prognosis.
It has been demonstrated that it is not necessary to remove the
paraffin to obtain usable spectral information, particularly in the
case of FTIR spectroscopy [28]. Standard tissue microarray
protocols involve paraffin embedded tissue. Leaving the paraffin in
place reduces scattering artefacts and effects of further variable
removal of aromatic solvent soluble components [28-31]. The
spectrally well defined paraffin contribution can be digitally
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removed in a preprocessing step, involving Independent
Component Analysis (ICA) and Non-Negatively Constrained Least
Squares Analysis (NCLS), so called digital dewaxing [28]. However, it
may be argued that greater consistency of spectral information is
achieved when sections are deparaffinised. Deparaffinising also
allows post-staining of the sections, although it has been
demonstrated that the efficiency of the deparaffinisation process
can depend on the tissue pathology [32]. Nevertheless, it can also
be argued that, even for research purposes, protocols for such
tissue processing should be maintained as close as possible to those
currently employed in the clinical environment.

Spectral Preprocessing: Raman spectroscopy
In the case of Raman spectroscopy, as-recorded spectra can suffer
from similarly additive and multiplicative contaminations as FTIR
spectra. Background, substrate and instrumental contributions are
routinely subtracted, whereas dealing with multiplicative
contributions from resonant or otherwise enhanced scatterers can
be more complex.
A similarly broad underlying spectral background is often observed
in Raman spectra of biological samples. In the case where the
sample contains fluorophores which are resonant at the source
wavelength, the background contributions are often eradicated by
spectral differentiation, as in the case of IR absorption spectra,
although the relatively higher wealth of spectral information in
Raman spectra means that the derivative spectra are difficult to
interpret [33].
In many cases, however, the background to the Raman spectra can
not easily be attributed to sample fluorescence, as it is unclear what
fluorophores in tissue, or even raw proteins, can give rise to a broad
fluorescence background, especially with near infrared sources [2].
More recently, it has been demonstrated that the background in
pure proteins at 785nm is dependent on sample morphology and
that measurement of tissue sections in water immersion effectively
eliminates the background, suggesting that an origin in stray light
from Mie scattering of the source laser line and even the Raman
bands themselves [34]. The study demonstrates that an important
route towards minimizing preprocessing is appropriate sample
presentation. When measured in immersion, the water acts as an
index matching fluid, visually reducing the scattering of the laser
spot by the sample (Figure 2) and significantly enhancing the
spectra (Figure 3), which can be preprocessed by subtraction of the
instrument response and the water contribution. Measurement in
water immersion also significantly reduces any photo damage in
tissue samples, the water providing a heat sink to protect from
photothermal effects [35].
In addition to background from the sample, in thin samples, the
substrate itself can contribute significantly, and the contribution
can be variable from sample to sample and difficult to remove
routinely. Choice of substrate can minimize this contribution, and
UV grade CaF2 is widely accepted as an optimal choice [36],
particularly as it is also compatible with IR transmission
measurement. In terms of potential clinical applications, however,
for example routine cytological screening, cost implications may
dictate that substrate choice is limited to conventional glass
microscope slides. In the development of Raman protocols for such
applications, choice of substrate is intimately linked with choice of
wavelength, and it has been demonstrated that, although
conventional glass microscope slides have a substantial background
at 785nm, this is greatly reduced at 532nm [2, 36].

Confocal operation, available in some Raman microspectrometers,
can reduce the spectral contribution of the substrate, as previously
described by Puppels et al. for single cells [37, 38]. Nevertheless,
when performing measurements on optically thin single cells grown
on a substrate, substrate contributions to the Raman spectra can
still be significant. Furthermore, confocal operation is not available
on many commercial spectrometers. Recent studies have
demonstrated the benefits of using 3D collagen gels for Raman
mapping of single live cells [39]. The substrate (collagen)
contribution to the spectrum is shown to be negligible, reducing the
requirement for substrate subtraction. Moreover the protein matrix
reduces the toxicity of the substrate enabling prolonged studies of
live cells even in full cell culture medium. Such extended mapping
periods are ideally required for full cellular and sub cellular analysis
to evaluate, for example, mechanisms of interaction of
nanoparticles or chemotherapeutic agents.

Figure 2: Laser spots obtained at the focus position on a skin sample
after chemical dewaxing in the dry state (A) and immersion (B).
(Reproduced from John Wiley and Sons [34])

Figure 3: Example of mean spectra recorded on two different
human skin samples from the thigh dry (A and B) and using the
immersion objective (respectively C and D). The first sample has
been dewaxed in hexane (A and D), the second using xylene (B and
C). (Reproduced from John Wiley and Sons [34])
In cases where the spectral background cannot be completely
eradicated experimentally, background removal is commonly
performed, by one of numerous algorithms [40, 41] e.g. one
automated approach is the implementation of the so-called EMSC
(extended multiplicative scatter correction) algorithm, originally
developed for IR spectroscopy [42]. Common semi-automated
computational methods of background subtraction are the
subtraction of a polynomial of certain order [43-45]. The so-called
“rubber band” model is derived from the commercially available
“Opus” software package commonly used on Bruker IR
spectrometers [46]. However, it should be noted that such
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subtraction of arbitrary backgrounds does not guarantee a
reproduction of the true spectral features, as a spectral minimum
between many overlapping Gaussian features may not be the true
minimum of the signal. Prior knowledge of the contributing factors
should be used, wherever possible. Accordingly, it is common to
record and subtract “dark” and substrate spectra from the sample
spectra before removing any arbitrary background. As the substrate
spectrum is an independent spectral component, it can effectively
be removed by ICA sand NCLS, in a similar process to the so-called
“digital dewaxing” of tissue spectra [28].
Further artifacts in Raman Spectroscopy include nonlinearity of axes
and dark noise. In dispersive multichannel Raman spectrometers
employing a CCD sensor, the data point spacing during acquisition
can be irregular not only due to the use of different gratings. It may
change from day to day due to different calibration settings and
even drift over the course of a day due to variations in temperature
and/or humidity. This leads to recordings with different abscissa
and abscissa-linearity which therefore induces variance in the xaxes. This issue of “transfer calibration” has been recognised in a
number of fields, notably in near IR spectroscopy in food science
and a number of protocols have been developed [47-49]. A number
of commercial instruments now incorporate a post recording
calibration procedure, although it is not clear as yet whether a
standard procedure has been adopted by the biospectroscopy
community.
As Raman spectroscopy measures scattered intensity, as opposed
to IR spectroscopy, which measures a transmission ratio, in addition
to calibration of the spectral axis, intensity calibration is necessary
in cases that the results from different instruments and laser
sources are to be compared. To this end, the use of Standard
Reference Materials (SRM) are desirable, e.g. those from the US
National Institute of Standards, Boulder, Colorado, USA (NIST SRM
2243, 2242, 2241). The use of SRM also provides a means to correct
Raman spectra for relative intensity on a day-to-day basis. The
application of such standards requires measurements of its
luminescence spectrum on the Raman instrument employed.
Subsequent mathematical treatment of both the observed
luminescence spectrum of the intensity standard and the observed
Raman spectrum of the measured sample create the intended
comparability of data between spectrometer and excitation lines.
The relative intensities of measured Raman spectra are corrected
for instrument specific response employing computational methods
using a correction curve. These curves are generated with certified
polynomials and pre-recorded fluorescence spectra of the SRM
glass (a manganese doped borate matrix glass).
Electronic noise, consisting of flicker noise, shot noise and thermal
noise is an unpredictable and constant occurrence primarily in the
spectral intensity, and can have a huge impact on the quality of any
signal [50] and Raman spectra are commonly additionally subjected
to a noise reduction protocol to “smooth” the spectra, increasing
the signal to noise and accentuating the true spectral features. A
common smoothing algorithm incorporated in commercial
instrument software is the Savitsky-Golay algorithm [51]. However,
it is important to be aware of the potential influence on spectral
features of order and window size of Savitzky-Golay filters for noise
reduction. Recently a systematic study of data preprocessing
techniques which considerably increase the confidence in the
reliability of pre-processed Raman spectra has been carried out
[46].
In both IR absorption and Raman spectroscopy, the measured
spectra are also influenced by spot to spot variations of sample
thickness and density, resulting in a variable overall signal intensity

reflective of the physical inhomogeneity rather than biochemical
changes related to pathology or biochemical process [521]. For
multivariate analysis, normalisation of variables into a relative
variable space is recommended. Ideally, an internal standard or
other pseudo-constant reference value to correct for the scaling
effects should be employed [53]. In the absence of an independent
internal standard, vector normalization is commonly employed. The
process weights each spectrum according to its integrated intensity
such that all samples contribute equally to the analysis model [54].
It is important that all background and/or baseline contributions are
removed before normalisation.

Data Analysis
Analysis of the subtle changes in spectral profiles associated with,
for example, disease, biological processes or the influence of
external agents require the use of multivariate analytical
techniques. Such multivariate methods have become invaluable to
a wide range of fields, including geology, pharmaceutical science,
pharmacology, astrophysics, imaging, and chemistry. Importantly,
these methods allow for complicated and also in some instances
very large datasets to be analysed and in effect they reduce the
dimensionality and complexity of the data allowing for meaningful
information to be extracted.
Specifically considering vibrational spectroscopic datasets,
multivariate methods allow analysis of multiple spectra
simultaneous and interdependently. This then allows for
comparisons to be made between spectra and groups of spectra
within a dataset and to identify trends these may contain e.g.
spectral markers of disease in control and non-control patients,
identification of nanoparticle containing spectra, response to
external agents etc.. Although they derive from distinct physical
processes, the approach to data processing is largely independent
of the analytical technique (IR absorption or Raman spectroscopy)
but is more dictated by the application (e.g. diagnostic
classification, spectral mapping, progression analysis).
An important consideration in the application of multivariate
methods to spectral data analysis is the requisite size of dataset.
Statistical significance is a critical consideration, and when patient
diagnosis is the outcome, misclassification has serious
consequences. Beleites et al., have carried out a study examining
the effects of sample size on multivariate classifier models for
clinical biospectroscopy [55]. It is demonstrated that, while learning
curves for dataset sizes common to small scale academic studies (225) can indicate acceptable performance, the model testing is itself
limited by the dataset size and that datasets of 75-100 samples are
required to produce “a good but not perfect classifier”.
In the construction of multivariate classifiers, robustness of the
model should also be rigorously tested. A commonly used
performance measure is the Standard Error of Prediction (SEP) [56].
If the data are normally distributed, the prediction errors are
generally within the tolerance interval of ±2 x SEP. However,
evaluation of the performance of a model on the complete dataset
acquired during a given experiment does not assess the potential
performance of the model in a practical situation where it is
presented with unseen data [56]. When the dataset is sufficiently
large, individual spectra may be considered normally distributed
and representative of the multivariate dataset that is likely to be
encountered in reality [56]. In such situations, the dataset may be
randomly sorted and split into calibration and test sets [56-59]. The
calibration set is used to find the optimal model for that dataset,
and the root-mean-squared error of calibration, (RMSEC), is
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computed. The generalization performance of the model is
determined by the root-mean-squared error of prediction (RMSEP)
for the test dataset. A significant difference between RMSEC and
RMSEP indicates that the model does not generalize well to unseen
data. Often the evaluation of the models performance is conducted
many times on different randomized splits of the calibration and
test datasets to give a comprehensive assessment of the
generalizability of the models [56]. Other model validation
techniques commonly employed include Leave one out cross
validation or up to 10-fold cross validation [60, 61]. Pérez-Guaita et
al. [62] more recently evaluated the use of permutation testing,
commonly used in metabolomics [63] and proteomics [64], which
employs a random reallocation of class labels in order to establish
the statistical significance of a cross-validation figure of merit of a
classifier. Ultimately, however, the validation of the integrated
techniques of spectroscopy and multivariate classifiers will have to
comply with the rigours of the clinical environment, including large
scale blind datasets and randomised trials [1].
In terms of post processing of multivariate spectral data, for
diagnostics the primary emphasis to date has been on unsupervised
classification. In this context, PCA has been used extensively. The
use of PCA has been extended to include for example analysis of
antibody activation of T-cells [65] and differentiation of embryonic
stem cells [66], and also in the differentiation of spectra from
different spatial locations within cells and tissues in spectral
imaging [67,68]. It has also been used in conjunction with other
multivariate methods such as Linear Discriminant Analysis to derive
clinically relevant estimates of the sensitivities and specificities of
the diagnostic protocols [69] and in comparative analyses of the
spectral content in various types of human cancer cell lines [70].
Hierarchical cluster analysis is similarly often employed for example
in the intercomparison of spectral classes in discrimination of
malignant and non-malignant tissues [71], and for visualising the
spatial distribution of identified components in spectral maps [72,
73]. Notably, however, for diagnostic applications, precise
information on the chemical determinants of the differentiation of
tissue types or sample regions is not required.
To extract information regarding the biochemical changes
underpinning the spectral changes, a more sophisticated data
processing toolbox is required. Supervised methods such as (Linear
and Nonlinear) Partial Least Squares Regression (PLSR) can be
employed to identify spectral variables which are specifically
correlated with an external agent [5, 6] or indeed an observed
physiological effect such as viability or proliferative capacity [7]. In
such studies, correlation with accepted or “gold standard” assays
can be used to guide and validate the interpretation of the
vibrational spectroscopic results. As well as standard
cytotoxicological assays, the spectroscopic results can be correlated
with more precise biomarkers, such as protein over-expression in
the case of HPV transfected cells [3, 4]. In advancing the
applications of biospectroscopy, it is crucial to establish multivariate
spectral equivalents of biomarkers which identify the action of for
example chemotherapeutic agents or nanotoxicants. Regression coefficients can play a critical role in the validation of the model and
provide indicators of the key contributions to the systematic
spectral variations. Feature selection models can often aid in
reducing the number of variables presented to the model. In PLSR,
PLS Jack-knifing has been demonstrated to allow the reduction of
the number of variables [74] avoiding over fitting and improving
performance. PLS Jack-knifing produces results that are readily
interpretable in terms of highlighting the systematic variation of
important spectral features within the regression model, and allows

visualization of PLSR coefficients and their uncertainty, and their
use in analysing spectroscopic responses associated with
chemotherapeutic agents has been demonstrated [6, 7].
Whereas PCA and PLSR, for example, may be considered linear
analytical methods, in that they attempt to describe the variability
of the dataset according to single parameters, multiparameter or
nonlinear statistical approaches can prove more powerful in
applications to biospectroscopical datasets which have a high
degree of variability. In this context, machine learning algorithms
such as Artificial Neural Networks have received considerable
attention [75]. Genetic algorithms (GA) and Support Vector
Machines are other options which have been successfully utilised in
multivariate regression problems [76] although direct visualisation
and therefore interpretation of the identified spectral variables is
not as simple.
A brief description of a selection of these multivariate methods
employed in spectral analysis is given in the following sections.
K-Means Cluster Analysis
K-means clustering analysis (KMCA) is a statistical method which
aims to partition data into clusters based on similarity. Firstly the
method chooses a number of seed locations which serve as initial
centroid locations in the dataset. Once a data point is assigned to
one of the seed locations, it changes to a centroid which serves as a
mean value of that cluster. The assignment of data points to
clusters is often based on the Euclidean distance between data
point and centroid, although other methods of calculating the
distance also exist [77]. After each spectrum has been assigned to a
centroid, the distance is then recalculated between each point and
centroid to see if any points are closer to another centroid location,
whereupon, if the point is closer to another cluster centroid, then it
is reassigned and both cluster centroids are changed as a result.
This process is completed for all data points until there is no
movement between clusters.

Figure 4. Schematic outlining the key steps in the K-Means
Clustering Analysis algorithm.
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From a spectroscopic imaging perspective, an initial number of seed
locations is chosen. The spectra are then assigned to one of the
seed locations. Once all spectra have been assigned, the mean
spectrum or centroid is calculated and the distance between each
spectrum and centroid is calculated. The spectra are then
reassigned if necessary and the process is iterated until no spectra
change groups. Figure 4 shows a diagram illustrating the main steps
in the K-means clustering algorithm.
(I)

(II)

different results. It is important to ensure enough iterations (50100) such that convergence is reached Secondly, looking at the
method to assess spectral imaging, each spectrum is assigned to
only one cluster, and the cluster is represented by the average of all
constituent spectra. As a spectrum may represent a number of
different biological entities in differing quantities, KMCA may be
correct in grouping a spectrum based on, for example, lipidic
distribution, but it may misclassify a spectrum which also contains a
small amount of another cluster’s biochemistry. There is no
weighting element introduced into the analysis so each spectrum
must belong to only one cluster.
Hierarchal Cluster Analysis
Hierarchal clustering analysis is a multivariate method which is
commonly used for clustering spectral data and generating images.
There are two main forms of HCA, agglomerative and divisive.
Agglomerative HCA is the more commonly used method. Briefly,
this method starts out with each data point or spectrum in a
separate group or cluster. The method then aims to group each
data point together in an iterative process until there is only one
cluster which contains all the data points. It is then possible to
construct an image based on how these clusters are linked
together. Often, the data can be represented using a two
dimensional dendrogram which shows the linkage between each
cluster. Divisive HCA on the other hand starts off with each
spectrum in one cluster and then aims to separate each data point
into one cluster.

(III)

Figure 5: I; (A) Microscopic image of an A549 cell, showing the
reduced area identified for spectral mapping. (B) K-means cluster
map of the Raman profile of the same reduced area. II; K-means
spectra of clusters 3 (A – representing nucleoli), 6 (B – representing
nucleus), 1 and 4 (C and D, both from the cytoplasm). Spectra are
offset for clarity. III; K-means spectrum of Cluster 5 (A), compared
to the Raman spectrum polystyrene nanoparticles (B). Spectra are
offset for clarity. (Reproduced from Royal Society of Chemistry [12])
In vibrational spectroscopy, KMCA has seen a number of uses to
separate spectra into clusters based on spectral similarities. As an
imaging tool, KMCA aims to separate each spectrum acquired in the
image and assign it to a cluster. This assignment is termed ‘hard’ in
that each spectrum is only assigned to one cluster. A good example
of KMCA in Raman spectroscopy is shown in the study by Dorney et
al. [12], in which it was used to identify regions in the Raman
dataset which correspond to polystyrene nanoparticles, and
differentiate them from neighbouring cytoplasm, as well as the
nucleus and nucleolus (Figure 5). Many other examples of KMCA as
a spectroscopic imaging reconstruction technique can be found in
the investigation of a wide range of samples including tissue
sections [78], cells [12, 79, 80] and in the analysis of human skin
[26, 81].
While this method has been shown to be useful in partitioning
spectra into clusters, it is important to highlight that the method is
not without certain pitfalls. Firstly, as the initial choice of centroid
location can be subjective, the reproducibility of the method can in
some instances be called into question i.e. if the initial starting
point of the analysis changes then it is possible to end up with

Figure 6: Showing a HCA dendrogram and both divisive and
agglomerative clustering.
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An example dendrogram is shown in Figure 6. An important point in
relation to HCA is that, once a group of spectra has been assigned
to a cluster or in the case of the agglomerative method merged into
a cluster, the spectrum cannot be reassigned, unlike KMCA where
the spectra can move clusters if closer to another centroid. This
means that HCA results in a very definite grouping of spectra into
clusters. In spectral datasets, it is assumed that all samples in a
study (with the exception of outliers) belong to the overall source
cluster, and individual spectra are clustered in an agglomerative
approach. Assigning spectra to a cluster is based on the pair-wise
similarity expressed as a matrix of correlation coefficients. The
threshold of similarity is somewhat subjective, although algorithms
are available to optimise performance [82, 83].
Although commonly performed in an unsupervised manner (UHCA),
HCA can also be performed in a supervised or semi-supervised
manner. UHCA is based on statistical similarity of the data but does
does not take any of the experimental variables such as treatment,
phenotype, tissue, etc. into account while clustering. In contrast,
supervised or semi-supervised clustering utilises such additional
information to “guide” or “adjust” the clustering process [84].
HCA is like KMCA in that the method is deemed to be a hard
clustering method with each spectrum being assigned to a specific
group. From an image reconstruction perspective, this means that
each pixel can only be assigned to one specific biochemical
grouping, which may not be reflective of the actual dataset. HCA
has been used in a classification method in number of studies
which include cellular studies [85] as well as in the investigation of
vibrational spectroscopy in diagnostics [86].
Vertex Component Analysis
Vertex component analysis (VCA) is another multivariate statistical
method which is used in spectral analysis [87]. The algorithm makes
an assumption that, contained within the dataset, are pure
endmember spectra which in turn can be used to describe all the
other spectra in the dataset. From this, abundance plots can be
generated via a linear combination of endmember spectra and
constructed into images which are described by the biochemical
information contained in these endmember spectra.
Recently, VCA has seen a number of applications in hyperspectral
imaging using both IR and Raman spectroscopy, with applications
including Raman histopathological imaging and also cellular studies
including nano-bio interactions [88] Importantly, while this method
can be used quite readily to reconstruct biochemical regions in the
cell, like all methods it may be prone to error. Firstly, as highlighted
by Chernenko et al. [88], endmember spectra may contain mixtures
of different biochemical components and while this may be
reflective of the actual nature of the sample, may lead to
inaccuracies in interpretation. Additionally, the method makes a
large assumption that the most extreme spectra in the dataset are
the most reflective of pure component spectra, which may not be
the case in complex biological spectra.
Fuzzy C – Means Clustering
Fuzzy C-means clustering (FCM) is a method which is similar to
KMCA in that it also assigns spectra to centroids in the datasets.
However, unlike KMCA, the method is a soft clustering method,
whereby each point or spectrum in the dataset is assigned a value
from 0 to 1, the value closest to 1 being representative of the
cluster centre. Therefore, by analysing the C centroid spectrum it is
possible to extract chemical information which describes each
reconstructed image. FCM has seen some usage in Raman
spectroscopy although primarily as an imaging method [79, 80].

Principal Components Analysis
Principal Components Analysis (PCA) is a method which aims to
reduce the dimensionality of the data to describe the variation
present in a dataset, whereby the first principal component is a
description of the maximum variance present in the dataset, the
second describes the second most variance, etc. The principal
component scores can then be described by the loading vector
which is an explanation of this variance. In a spectroscopic context,
the scores represent values which correspond to a loading
spectrum which contains peaks, both positive and negative which
explains the spectral variation in the dataset.
This tool can be quite useful for providing a method to separate
spectra into groups e.g. diseased and non-diseased [69]. It has also
been used to reconstruct images [79,80] i.e. a variance plot based
on the loadings plot. However, as these loadings plots may often
contain a number of spectral features corresponding to different
cellular biochemistry, interpretation can be difficult and it is quite
possible to misinterpret.
Bonnier et al. have shown that pairwise PCA of clusters identified by
KMCA can provide a clearer picture of the specific biochemical
differences between regions [89]. In simulated mixtures of multiple
components, the loadings can be seen to be weighted linear
combinations of the spectra of the contributing spectra, as shown in
Figure 7. As an example of the benefits of this approach, the dose
dependent spectral changes induced by simulated solar radiation in
the basal layer of a reconstructed skin model could be tracked
according to the loading of the first principle component of the
variation of the irradiated skin section compared to control [90].

Figure 7: Mean Raman spectra recorded from RNA (A), histone
(B) and ceramide (C) on CaF2 windows. II: Scores plot of the 2
first principal components after PCA performed on Raman
spectra recorded from RNA, histone and ceramide. III: Plot of
the loadings of PC1 (blue dot line) compared with the
difference spectrum calculated from the mean spectrum of
ceramide minus the mean spectrum of RNA (red dash line).
The loadings are compared with spectra recorded from
ceramide (A) and RNA (C), both offset for clarity. IIIB: Plot of
the loadings of PC2 (blue dot line) compared with the
difference between the mean spectrum of histone minus the
average mean spectrum of RNA and ceramide (red dash line).
(Reproduced from Royal Society of Chemistry [89])
Classic Least Squares Analysis – supervised/Unsupervised
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Classic Least Squares Analysis (CLSA) can be carried out in two
different ways, either by generating spectral models using a factor
analysis algorithm (unsupervised), or by manually inputting the
component spectra (supervised).
The analysis method is based on a fit of a linear combination of
reference component spectra to the spectra contained in the raw
spectral map. There are two different ways to obtain the reference
component spectra. The first way is to obtain a pure spectral
reference from a compound or compounds which can then be
fitted. The second method uses a factor analysis algorithm to
generate the component spectra, the weighted sum of which is
compared to the Raman spectral data set. Using the latter of the
two methods, Zavaleta et al. demonstrated the power of the
technique to quantify quantum dot accumulation in an in-vivo
mouse model and to separate out the different spectral
contributions from complex SERS signals in the same data set [91].
In a similar and different way, both approaches to CLSA were
explored to extract spectra which contain polystyrene nanoparticles
from a cellular Raman map and define other biochemical regions
such as the RNA and lipid rich environments [13]. The example of
the unsupervised CLSA analysis map is shown in Figure 8.
Notably, however, the unsupervised approach generates
factors which are mixtures between different components. In
the supervised case, the pure spectra are input into the
analysis and a map of the relative contributions is similarly
generated. However, for the same case of polystyrene, RNA
and lipids in a subcellular environment, all individual
components generated a background over the whole cell area
and a thresholding of the data was required to produce a
trustworthy image. Although such a thresholding procedure is
somewhat arbitrary, the support of simulated datasets can add
confidence to the procedure [13].

Figure 8: Clustering of spectra identified by unsupervised CLSA. (A)
Spectral models generated from the analysis protocol and used to
generate the clustered map shown in (B). The right panel (C-I)
shows the distribution of each model created in the map. Of
particular note, model 1(C), model 6(D) and model 7(H) have strong
contributions of the spectra of polystyrene, RNA and lipid
respectively. The spectra in (A) are colour coded and correspond to

images (B – F), with the exception of Model 6 which corresponds to
the white image in (D). (Reproduced from Royal Society of
Chemistry [13])
Spectral Cross Correlation Analysis
A novel analytical technique of Spectral Cross Correlation Analysis
(SCCA) was also applied to the data set analysed in Figure 7 [13].
For SCCA, reference spectra from polystyrene, phosphatidylethanolamine and RNA (Figure 9) were used to screen the Raman
spectral data set using a cross-correlation algorithm. The cross
correlation function integrates the product of the two data series
(spectra) at each point as they are shifted relative to each other
along the x axis (wave number). The magnitude of the correlation
quantifies the relative contribution of the component spectrum at
that point in the cell, and an exact correlation occurs when the
spectra are exactly matched (auto-correlation). In this way, it is
possible to screen the map or spectra in the map and, based on the
cross correlation function, cluster different biochemical regions of
the cell based on the relative contributions of the reference
spectrum used. 
The results of such a SCCA of the subcellular localisation of
polystyrene, RNA and 3-sn-phosphatidyl ethanolamine is shown in
figure 9. Similar to the case of unsupervised CLSA, a considerable
background of each component across the cell is observed initially,
and a thresholding procedure was required to improve the
precision of the technique. Simulated datasets generated for SCCA
provided a good estimation of where this thresholding should take
place and in combination with cellular data containing no
nanoparticles it was possible to accurately reveal where the
nanoparticles were located in the cell.

Figure 9: SCCA analysis using component spectra of polystyrene (A),
3-sn-phosphatidyl ethanolamine (B) and RNA (C). The spectrum of
each pure component is shown on the left of the figure and the
correlation maps for non-thresholded shown in the middle and
thresholded on the right. (Reproduced from Royal Society of
Chemistry [13])
Partial Least Squares Regression
Recently, regression modelling has seen a number of biomedical
applications in both Raman and IR spectroscopies. Partial least
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squares regression (PLSR) is an analytical technique which aims to
match a test data set to a series of targets. The core idea of using
this method is to investigate the spectral variability as a function of
a systematic conditional change such as radiation dose [5] or viral
infection [4]. PLSR can be employed to construct predictive models
for spectral response as a function of the target variable. Therefore,
an unknown dose or degree of infection can be determined from its
spectrum, having obvious potential clinical applications.
Furthermore, feature selection techniques such as PLSR coefficients, Jack-Knifing (JK) and genetic algorithms, amongst others
[92], can be employed to identify the most statistically relevant
spectral changes, such that the biological mechanisms underlying
the spectral changes can explored and understood.
A good practical example of this method in action in Raman spectral
data is outlined in two studies by Nawaz et al., [6,7] in which, the
aim was to investigate the capability of Raman as a technique to
study drug interactions in cells and the physiological response.
Looking specifically at cisplatin as an example chemotherapeutic
drug, these studies were able to extract information relating to drug
action in the cells via regression of the Raman dataset against
cytotoxicological data and dose, extracting out features from the
Raman spectra which correspond to changes to protein
conformation and structural alterations of DNA [6]. A further study
by Keating et al. demonstrated the validity of the technique, as well
as potential pitfalls, resulting for example from cross contamination
of targets for limited data ranges, using simulated datasets in which
the systematically varied drug dose and cell viability dependent
spectral variables were known [93].
Importantly, while these studies show the potential of Raman
spectroscopy and PLSR as tools for studying drug interaction, PLSR
used in this capacity is only relevant if the processes studied are in
themselves linear. However, most pharmacological actions are nonlinear processes and thus using a linear method to model a nonlinear process may be subject to error. Thus, additional forms of
validation of these methods in a spectral setting are necessary.
Artificial Neural Networks
Artificial neural networks (ANN’s) are considered ‘nonparametric
nonlinear regression estimators’ [75, 94] because of their ability to
determine relationships between one or more input or
‘independent’ variables and one or more output or ‘dependent’
variables, regardless of the form of the function defining the
relationship between the two sets of variables. Inspired by
biological neural networks, their popularity stems from their
general applicability to any problem [95], and they have seen
applications in radiation science to dose-dependent models for flow
cytometric analysis [96], for the prediction of depth dose in
radiotherapy [97], and for neutron dosimetry [98]. Udelhoven et al.
have demonstrated the use of artificial neural networks in
conjuction with a hierarchical classification of FT-IR spectra for the
identification of bacteria [99], while Lasch et al. have demonstrated
the use of Artificial neural networks as supervised techniques for
FT-IR microspectroscopic imaging [100]. ANN’s have the potential to
‘over-fit’ noisy features within the input variables if the model is
overly complex [75,94], and careful training and rigorous evaluation
of the network is required to prevent this.
Genetic Algorithm
Calibration models are known to be greatly improved through the
application of efficient feature selection methods, increasing the
predictive ability and reducing model complexity. One such method
is the adaptive search technique known as the genetic algorithm

(GA). A GA based variable selection procedure is used to reduce the
original spectra to a subset of wavenumbers to correlate the
spectra to response. The first generation for evaluation is a random
population consisting of a number of individuals or “chromosomes”,
each containing a subset of the original variables. Each
chromosome is composed of a vector of 1s and 0s, corresponding
to the wavenumbers in the X matrix, (1 if selected and 0 if not)
where each wavenumber is termed a “gene”. The performance of
models resulting from each chromosome is determined by means
of a fitness function (e.g. the root mean square error of cross
validation is used). Once each generation is evaluated, a new set of
chromosomes is produced by retaining and “crossing” over the
fittest individuals from the previous generation. “Mutations” are
also produced which force the evaluation of new combinations
avoiding saturation with similar sets of events and can further lower
the number of variables and fitness values. The process continues
until the difference in mean fitness level between successive
generations is below a certain threshold, whereupon the GA is
terminated to avoid over-training and avoid the risk of over fitting
[101-103].
Genetic algorithms have found a number of applications in
biospectroscopy, including in selection of preprocessing parameters
for multivariate regression [104], as well as feature selection
[76,105, 106].

Summary and Conclusions
Much progress has been made in recent years towards
understanding the confounding factors which influence the
integrity of vibrational spectra of biological tissues and cells. The
potential of the techniques for biomedical and biochemical analysis
applications lies in the ability to fingerprint the biochemical
content, and changes to it, at a molecular level, in a label free
manner. Such samples are intrinsically chemically and physically
inhomogeneous, however, and it is important to differentiate the
intrinsic biochemical profiles from confounding factors associated
with sample scattering of instrumental responses.
In this context, a fundamental starting point is the quality of the
recorded spectra, which can be influenced by sample presentation
and measurement protocols. In IR absorption, wax embedded
samples have been shown to exhibit minimal scattering artefacts,
and measurement in attenuated total reflectance or using an
integrated sphere can also reduce the associated spectral
distortions. In Raman spectroscopy, large stray light backgrounds
due to scattering of the source as well as the Raman bands
themselves can be minimised by measurement in immersion, the
water acting as an index matching fluid.
In both modalities, background can be minimised by appropriate
choice of substrate. However, for applications in a clinical
environment, cost implications may be a determining factor. In the
case of IR for ex vivo clinical applications, a current imperative is to
establish whether the spectral distortion associated with the EFSW
effect are sufficient to dominate over the spectral variations
associated with the pathological target, a consideration which may
determine whether low cost, low-E slides can be employed for
routine screening in the transflection mode, or whether more
expensive transmissive slides are required.
The validation of the RMieEMSC correction algorithm using
simulated datasets, in which known target spectra were distorted
with various degrees of “dispersion artefacts” as well as other
instrumental factors, demonstrates the importance of establishing
confidence in the data processing protocol, based on knowing the
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“right answer” [20]. A similar approach was taken by Keating et al.,
in exploring the relative merits of supervised and unsupervised CLS
as well as SCCA in the biochemical profiling of subcellular spectral
maps [13], as well as the validity of PLSR of spectral data against
dose and cytotoxicity dependent targets to yield independent
information regarding the direct chemical interaction of drugs
within cells, and the subsequent, indirect cytological responses [93].
To date, a range of multivariate analytical techniques have been
developed and applied to biospectroscopic datasets, in an academic
context. Depending on the application, linear or nonlinear,
supervised or unsupervised, may be most appropriate, although no
extensive comparison of the range of techniques has been
undertaken. Given the range of protocols for both pre and post
processing, it would be of great benefit to the research community,
and for the standardisation of protocols, towards clinical
translation, to similarly validate all protocols against an established
simulated dataset.
Regardless of the techniques applied or specific target application,
it remains of critical importance that all details of data pre- and
post- processing procedures are provided in publications. It remains
similarly important to cross reference the spectral analysis with
established biological or so-called “gold standard” clinical assays.
Although clinical histology and cytology is primarily based on
morphological changes, it is important to demonstrate that the
analysis of the underlying biochemical changes can augment
established practices, and ultimately improve on the understanding
of disease onset and progression. Critically, while the research
environment has demands on demonstrating the reproducibility of
data, the demands of clinical deployment are substantially more
rigorous. Studies must, therefore, be extended to use of a clinically
appropriate scale and statistical analysis to be considered
meaningful.
In terms of applications such as screening for modes of actions and
efficacies of, for example, chemotherapeutic agents, correlation
with established biochemical assays can help to establish spectral
markers, which could lay the foundation for the development of
high content, label free analysis based on spectral-omics.
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